Literature DB >> 9387801

Disturbances in higher function in Parkinson's disease.

F Tamaru1.   

Abstract

The most striking of the cognitive deficits in Parkinson's disease is 'subcortical dementia', which is similar to the cognitive deficits caused by frontal lobe damage. Of the several causes of the cognitive deficits in Parkinson's disease, the most interesting theoretical mechanism is the dysfunction of the cortical-basal ganglionic circuits connecting the frontal lobe and the basal ganglia. As the activity of these circuits can be modulated at the striatum by the nigrostriatal dopaminergic system, cognitive function can be influenced by the pathological change in the substantia nigra in Parkinson's disease. As a result of the dysfunction of this system, disturbances of memory, attention, and executive function occur. Our study found that the dopaminergic system plays a role in the disturbance of the set-shifting ability in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9387801     DOI: 10.1159/000113474

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

Review 1.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

2.  Predictors of HVOT performance in Parkinson's disease.

Authors:  Christopher I Higginson; Vicki L Wheelock; Dawn Levine; Conrad T E Pappas; Karen A Sigvardt
Journal:  Appl Neuropsychol       Date:  2011-07

3.  Executive dysfunction in subcortical ischaemic vascular disease.

Authors:  J H Kramer; B R Reed; D Mungas; M W Weiner; H C Chui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 4.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.